The cysteine-rich interdomain region from the highly variable plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure.
Plasmodium falciparum malaria parasites, living in red blood cells, express proteins of the erythrocyte membrane protein-1 (PfEMP1) family on the red blood cell surface. The binding of PfEMP1 molecules to human cell surface receptors mediates the adherence of infected red blood cells to human tissues. The sequences of the 60 PfEMP1 genes in each parasite genome vary greatly from parasite to parasite, yet the variant PfEMP1 proteins maintain receptor binding. Almost all parasites isolated directly from patients bind the human CD36 receptor. Of the several kinds of highly polymorphic cysteine-rich interdomain region (CIDR) domains classified by sequence, only the CIDR1alpha domains bind CD36. Here we describe the CD36-binding portion of a CIDR1alpha domain, MC179, as a bundle of three alpha-helices that are connected by a loop and three additional helices. The MC179 structure, containing seven conserved cysteines and 10 conserved hydrophobic residues, predicts similar structures for the hundreds of CIDR sequences from the many genome sequences now known. Comparison of MC179 with the CIDR domains in the genome of the P. falciparum 3D7 strain provides insights into CIDR domain structure. The CIDR1alpha three-helix bundle exhibits less than 20% sequence identity with the three-helix bundles of Duffy-binding like (DBL) domains, but the two kinds of bundles are almost identical. Despite the enormous diversity of PfEMP1 sequences, the CIDR1alpha and DBL protein structures, taken together, predict that a PfEMP1 molecule is a polymer of three-helix bundles elaborated by a variety of connecting helices and loops. From the structures also comes the insight that DBL1alpha domains are approximately 100 residues larger and that CIDR1alpha domains are approximately 100 residues smaller than sequence alignments predict. This new understanding of PfEMP1 structure will allow the use of better-defined PfEMP1 domains for functional studies, for the design of candidate vaccines, and for understanding the molecular basis of cytoadherence.
Klein
Michael M
MM
Structural Biology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Gittis
Apostolos G
AG
Su
Hua-Poo
HP
Makobongo
Morris O
MO
Moore
Jaime M
JM
Singh
Sanjay
S
Miller
Louis H
LH
Garboczi
David N
DN
D000818:Animals; D001665:Binding Sites; D018955:CD36 Antigens / Q000378:metabolism; D003545:Cysteine; D010963:Plasmodium falciparum / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D015800:Protozoan Proteins / Q000737:chemistry* / Q000378:metabolism
D018955:CD36 Antigens; D015800:Protozoan Proteins; C085731:erythrocyte membrane protein 1, Plasmodium falciparum; D003545:Cysteine
Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1772-9
12351820
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2664-9
11226296
Mol Biochem Parasitol. 2004 Sep;137(1):55-64
15279951
Mol Microbiol. 2003 Jul;49(1):179-91
12823820
Methods Enzymol. 1997;276:472-494
27799110
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1766-71
10677532
Mol Biochem Parasitol. 2006 Aug;148(2):169-80
16697476
Blood. 2005 Mar 15;105(6):2557-63
15345591
J Infect Dis. 2006 Mar 1;193(5):731-40
16453270
Cell. 1995 Jul 14;82(1):77-87
7541722
Cell. 2005 Jul 29;122(2):183-93
16051144
Nature. 2006 Feb 23;439(7079):1004-8
16382237
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2256-68
15572779
Mol Microbiol. 2008 Jan;67(1):78-87
18047571
Mol Biochem Parasitol. 2000 Oct;110(2):293-310
11071284
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3860-5
11904437
J Mol Biol. 2005 Mar 4;346(4):1047-57
15701516
Science. 1989 Mar 17;243(4897):1469-71
2467377
Blood. 2003 Jan 1;101(1):331-7
12393525
Cell. 1989 Jul 14;58(1):95-101
2473841
Blood. 1997 Nov 1;90(9):3766-75
9345064
Cell. 1995 Jul 14;82(1):101-10
7606775
Cell Microbiol. 2006 Sep;8(9):1371-81
16848786
Mol Microbiol. 2003 Mar;47(5):1265-78
12603733
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
9757107
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15835-40
17895392
Curr Opin Microbiol. 2006 Aug;9(4):374-80
16814594
Bioinformatics. 2004 Feb 12;20(3):426-7
14960472
Gene. 2006 Aug 15;378:19-30
16806741
Nature. 1992 Jun 25;357(6380):689-92
1614515
Parasite Immunol. 2005 Oct-Nov;27(10-11):373-84
16179031
FEMS Immunol Med Microbiol. 2004 May 1;41(1):9-26
15094163
Nature. 2002 Oct 3;419(6906):498-511
12368864
Acta Crystallogr D Biol Crystallogr. 1996 Jul 1;52(Pt 4):842-57
15299650
J Mol Biol. 2007 Sep 21;372(3):774-97
17681537
Acta Crystallogr D Biol Crystallogr. 2000 Aug;56(Pt 8):965-72
10944333
Comput Chem. 1994 Sep;18(3):269-85
7952898
J Clin Invest. 1989 Sep;84(3):765-72
2474574
Trends Microbiol. 2002 Feb;10(2):55-8
11827798
PLoS One. 2007 Sep 19;2(9):e910
17878945
J Mol Biol. 1993 Dec 20;234(4):946-50
8263940
Curr Mol Med. 2006 Mar;6(2):187-203
16515510
PLoS Pathog. 2008 Feb 8;4(2):e42
18282103
Infect Immun. 2008 May;76(5):1837-47
18299339
Blood. 2001 May 15;97(10):3268-74
11342458
Mol Biochem Parasitol. 2004 Feb;133(2):255-65
14698437
Nature. 2002 Feb 7;415(6872):673-9
11832955
Mol Biochem Parasitol. 1998 Nov 30;97(1-2):133-48
9879893
J Clin Invest. 1989 Aug;84(2):468-75
2474569
Annu Rev Microbiol. 2001;55:673-707
11544371
Malar J. 2003 Sep 10;2:27
14565852
BMC Genomics. 2007 Feb 07;8:45
17286864
PLoS Pathog. 2006 Nov;2(11):e124
17112315
Mol Microbiol. 1998 Oct;30(1):83-90
9786187
Curr Opin Microbiol. 2005 Aug;8(4):434-40
15979386
PLoS Pathog. 2007 Mar;3(3):e34
17367208
Am J Trop Med Hyg. 1997 Oct;57(4):389-98
9347951
Trends Parasitol. 2003 Oct;19(10):461-9
14519584
Cell. 1995 Jul 14;82(1):89-100
7606788
Mol Biochem Parasitol. 2002 Apr 9;120(2):321-3
11897140
Nature. 2006 Feb 9;439(7077):741-4
16372020